GO:0043116 negative regulation of vascular permeability: Barrier Protection, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043116 (negative regulation of vascular permeability) describes any process that reduces the extent to which blood vessels can be pervaded by fluid, thereby preserving vascular barrier function.
• Endothelial adherens junctions, especially VE-cadherin complexes, are central targets whose stabilization directly lowers permeability.
• The endothelial glycocalyx acts as a primary physical and signaling barrier that limits fluid extravasation.
• Neuropilin-1 (NRP1) controls vascular permeability through juxtacrine regulation of endothelial adherens junctions.
• Dysregulated vascular permeability contributes to sepsis-associated encephalopathy, hypertension, atherosclerosis, and age-related blood-brain barrier decline.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of candidate genes in negative regulation of vascular permeability.
Description
Negative regulation of vascular permeability (GO:0043116) is the biological process that reduces the extent to which blood vessels can be pervaded by fluid. This process is essential for maintaining the semipermeable endothelial barrier that separates blood from interstitial tissues, and its failure leads to edema, inflammation, and organ dysfunction. Researchers study this term because it defines the protective arm of vascular barrier control, distinct from pathways that increase leakage. The endothelium is not a passive tube; it actively integrates junctional, glycocalyx, and signaling inputs to restrict fluid flux. Understanding how these inputs are negatively regulated is central to diseases such as sepsis-associated encephalopathy, hypertension, and atherosclerosis. Recent work has identified Neuropilin-1 as a juxtacrine regulator of endothelial adherens junctions that controls vascular permeability. The endothelial glycocalyx is also recognized as a key barrier whose integrity limits fluid extravasation. In the skin, blood vascular permeability is tightly regulated under physiological and pathological conditions. Age-related shifts in transcytosis impair physiological blood-brain transport, highlighting the importance of maintaining negative regulation of permeability over time. This article synthesizes the QuickGO definition and verified PubMed literature to provide a research-grade overview of GO:0043116, its mechanisms, key genes, disease links, and experimental methods.
negative regulation of vascular permeability At A Glance
| GO ID | GO:0043116 |
|---|---|
| GO term | negative regulation of vascular permeability |
| Ontology | biological_process |
| Synonym | down regulation of vascular permeability; down-regulation of vascular permeability; downregulation of vascular permeability; inhibition of vascular permeability |
| Major function | Reduces the extent to which blood vessels can be pervaded by fluid, preserving endothelial barrier function. |
| Key cellular structures | Endothelial adherens junctions and the endothelial glycocalyx. |
| Representative regulator | Neuropilin-1 (NRP1) controls vascular permeability through juxtacrine regulation of endothelial adherens junctions. |
| Disease relevance | Sepsis-associated encephalopathy, hypertension, atherosclerosis, and age-related blood-brain barrier decline. |
| Research methods | CRISPR knockout, knock-in, overexpression, imaging, and permeability assays. |
What Is GO:0043116?
GO:0043116, negative regulation of vascular permeability, is defined by QuickGO as any process that reduces the extent to which blood vessels can be pervaded by fluid. In practice, this means molecular and cellular events that strengthen the endothelial barrier, stabilize cell-cell junctions, reinforce the glycocalyx, or otherwise decrease the passive and active movement of fluid across the vessel wall.
Why Is negative regulation of vascular permeability Important in Cell Biology?
Negative regulation of vascular permeability is important because it protects tissues from edema, maintains blood-brain barrier function, and limits inflammatory damage. When this process fails, fluid and solutes leak into interstitial spaces, contributing to diseases such as sepsis-associated encephalopathy, hypertension, and atherosclerosis. Experimental models that manipulate genes controlling this process are therefore essential for understanding disease mechanisms and identifying therapeutic targets.
• Maintains the endothelial barrier that separates blood from interstitial fluid.
• Prevents edema and tissue swelling in inflammatory conditions.
• Preserves blood-brain barrier function and physiological transport.
• Limits vascular leakage in sepsis-associated encephalopathy.
• Contributes to vascular homeostasis in hypertension and atherosclerosis.
• Involves Neuropilin-1-dependent control of adherens junctions.
• Is influenced by metabolic and hypoxic signaling pathways.
• Provides therapeutic targets for barrier-protective strategies.
• Can be studied with CRISPR-based causal genetics.
• Relevant to age-related decline in blood-brain transport.
What Happens During negative regulation of vascular permeability?
Stabilization of endothelial adherens junctions
In simple terms: Cells that line blood vessels are glued together by junction proteins; keeping these junctions strong stops fluid from leaking out.
Endothelial adherens junctions are key structures whose stabilization reduces vascular permeability. Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions, indicating that junctional complexes are direct effectors of negative regulation. Strengthening these junctions decreases the extent to which blood vessels can be pervaded by fluid.
Maintenance of the endothelial glycocalyx
In simple terms: The glycocalyx is a sugar-rich coating on the inside of blood vessels that acts like a protective gel layer.
The endothelial glycocalyx is a critical barrier that limits fluid extravasation and contributes to negative regulation of vascular permeability. Its composition and integrity are essential for restricting the movement of fluid across the vessel wall. Loss of glycocalyx components is associated with increased permeability.
Regulation by juxtacrine signaling
In simple terms: Cells can talk to their immediate neighbors by direct contact, and this contact can tell the vessel wall to stay sealed.
Neuropilin-1 mediates juxtacrine regulation of endothelial adherens junctions, providing a contact-dependent mechanism that reduces vascular permeability. This signaling mode ensures that barrier strengthening is spatially restricted to interacting cells.
Integration of metabolic and hypoxic signals
In simple terms: Cellular stress signals such as low oxygen or high sugar can change how leaky blood vessels are.
Hypoxia-inducible factor-1 alpha regulates permeability of vascular endothelial cells, linking oxygen sensing to barrier control. Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway, showing that metabolic signals can modulate endothelial barrier properties. These pathways can either promote or oppose negative regulation of vascular permeability depending on context.
Barrier protection in specific vascular beds
In simple terms: Different organs have different blood vessel barriers, and the skin and brain have specialized control systems.
Regulation of blood vascular permeability in the skin involves distinct mechanisms that maintain barrier function under physiological conditions. In the brain, physiological blood-brain transport is impaired with age by a shift in transcytosis, indicating that negative regulation of permeability is dynamically maintained. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy, highlighting how loss of barrier protection contributes to disease.
Key Genes Involved in GO:0043116 negative regulation of vascular permeability
The following genes and proteins have been experimentally linked to negative regulation of vascular permeability or to its disruption in disease models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NRP1 | Controls vascular permeability through juxtacrine regulation of endothelial adherens junctions | Direct regulator of adherens junction stability and barrier function |
| CDH5 (VE-cadherin) | Core component of endothelial adherens junctions | Target for junction stabilization studies |
| POLDIP2 | Mediates blood-brain barrier disruption in sepsis-associated encephalopathy | Loss-of-function models show barrier protection when inhibited |
| HIF1A | Regulates permeability of vascular endothelial cells | Hypoxia-linked modulation of endothelial barrier |
| GLI1 | Hedgehog pathway effector involved in metformin-mediated endothelial protection | Metabolic regulation of endothelial impairment |
| PTCH1 | Hedgehog pathway receptor linked to autophagy downregulation in endothelium | Upstream regulator of endothelial barrier protection |
| SMO | Hedgehog pathway transducer in endothelial cells | Potential target for modulating permeability |
| MAP1LC3B | Autophagy marker downregulated by metformin in endothelium | Readout of autophagy-dependent endothelial impairment |
| SDC1 (Syndecan-1) | Glycocalyx component contributing to barrier function | Marker of glycocalyx integrity and permeability |
| GPC1 (Glypican-1) | Glycocalyx component involved in endothelial barrier | Candidate for glycocalyx-focused studies |
| HSPG2 (Perlecan) | Glycocalyx-associated proteoglycan | Structural support for barrier function |
| ALB | Plasma protein used to measure vascular leak | Readout of permeability in skin and other tissues |
| VEGFA | Classic permeability-increasing factor used as a challenge in barrier assays | Negative control for barrier-protective interventions |
| CLDN5 | Tight junction protein contributing to blood-brain barrier integrity | Target for age-related barrier studies |
| OCLN | Tight junction protein supporting blood-brain barrier function | Readout of barrier maintenance |
| TJP1 (ZO-1) | Scaffolding protein at tight junctions | Marker of junctional integrity |
| NFKB1 | Inflammatory transcription factor linked to barrier disruption | Target for anti-inflammatory barrier protection |
How Is negative regulation of vascular permeability Regulated?
Negative regulation of vascular permeability is controlled by multiple signaling inputs. Neuropilin-1 provides juxtacrine regulation of endothelial adherens junctions, directly stabilizing the barrier. The endothelial glycocalyx is dynamically maintained and its integrity is required for limiting fluid extravasation. Hypoxia-inducible factor-1 alpha regulates endothelial cell permeability, linking oxygen tension to barrier function. Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway, showing that metabolic and Hedgehog signals converge on endothelial barrier control. In sepsis-associated encephalopathy, Poldip2 mediates blood-brain barrier disruption, indicating that inflammatory pathways can override protective mechanisms. Age-related shifts in transcytosis impair physiological blood-brain transport, demonstrating that negative regulation of permeability changes over the lifespan.
negative regulation of vascular permeability and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLDIP2 | Sepsis-associated encephalopathy | Knockout or knockdown in endothelial cells followed by barrier assays |
| NRP1 | Vascular permeability regulation | Knockout and knock-in models to test adherens junction stability |
| HIF1A | Hypoxia-linked endothelial permeability | Point mutation or knockout under hypoxic conditions |
| GLI1 | Hyperglycemia-induced endothelial impairment | Overexpression or knockout with metformin treatment |
| CLDN5 | Age-related blood-brain barrier decline | Knock-in reporter for tight junction dynamics |
Sepsis-associated encephalopathy
Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy, showing that loss of negative regulation of vascular permeability contributes to neuroinflammation and brain dysfunction. Targeting Poldip2 or its downstream effectors may restore barrier protection.
Hypertension and atherosclerosis
Gut microbiota are implicated in hypertension and atherosclerosis, conditions in which endothelial barrier dysfunction and altered vascular permeability play important roles. Negative regulation of vascular permeability is therefore relevant to cardiovascular disease mechanisms.
Age-related blood-brain barrier decline
Physiological blood-brain transport is impaired with age by a shift in transcytosis, indicating that negative regulation of vascular permeability becomes less effective over time. This has implications for neurodegeneration and drug delivery.
Metabolic endothelial impairment
Hyperglycemia-induced endothelial impairment involves autophagy and Hedgehog signaling, and metformin alleviates this impairment by downregulating autophagy. This links metabolic disease to negative regulation of vascular permeability.
From negative regulation of vascular permeability-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase vascular permeability? | CRISPR knockout in endothelial cells followed by permeability assays |
| Does a specific point mutation in an adherens junction gene alter barrier function? | Point-mutation knock-in in endothelial cells |
| Does overexpression of a protective gene reduce permeability? | Overexpression cell model with barrier readouts |
| Where and when is a barrier-protective protein expressed? | Tagged knock-in with imaging |
| Does a metabolic intervention require a specific gene for barrier protection? | Knockout plus metformin treatment |
| Does hypoxia signaling modulate endothelial permeability? | Knockout or point mutation under hypoxic conditions |
How to Study the negative regulation of vascular permeability Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transendothelial electrical resistance | Barrier tightness of endothelial monolayers | Screening for genes that negatively regulate permeability |
| Albumin flux assay | Movement of albumin across vessel wall | Quantifying vascular leak in skin and other tissues |
| Immunofluorescence | Localization of junctional proteins | Assessing adherens junction stability |
| Glycocalyx staining | Integrity of the endothelial glycocalyx | Evaluating barrier protection |
| CRISPR knockout | Loss-of-function effects on permeability | Causal testing of candidate genes |
| CRISPR knock-in | Effects of specific mutations or tags | Studying point mutations in barrier genes |
| RNA sequencing | Transcriptional changes after perturbation | Identifying pathways linked to permeability |
| In vivo permeability imaging | Real-time vascular leak in animals | Testing barrier-protective interventions |
Permeability assays
Permeability assays measure the movement of fluid or tracers across endothelial monolayers or in vivo vascular beds, providing direct readouts of negative regulation of vascular permeability. Albumin flux is commonly used to quantify leak in skin and other tissues.
Junctional and glycocalyx imaging
Imaging of adherens junctions and the endothelial glycocalyx reveals structural changes that underlie barrier protection. Neuropilin-1-dependent junctional regulation can be visualized by co-staining approaches.
Genetic perturbation with CRISPR
CRISPR knockout, knock-in, and overexpression models allow causal testing of candidate genes in negative regulation of vascular permeability. These approaches can distinguish correlation from causation in barrier biology.
Transcriptomic and pathway analysis
RNA sequencing and pathway analysis identify signaling networks, such as Hedgehog and hypoxia pathways, that modulate endothelial permeability. These methods help prioritize genes for functional validation.
How CRISPR Can Be Used to Study GO:0043116 negative regulation of vascular permeability
Knockout
CRISPR knockout of candidate genes such as NRP1 or POLDIP2 can test whether they are required for negative regulation of vascular permeability. Loss-of-function models reveal whether a gene protects the endothelial barrier or promotes leakage.
Point Mutation
Point-mutation knock-in can model specific amino acid changes in junctional or signaling proteins to determine how they affect barrier function. This approach is useful for studying disease-associated variants in genes controlling vascular permeability.
Knock-in
Tagged knock-in of genes such as CLDN5 or NRP1 allows visualization of protein localization and dynamics in endothelial cells. Knock-in reporters can be used to track barrier changes over time.
Overexpression
Overexpression of protective genes, such as components of the Hedgehog pathway, can test whether increasing their levels reduces permeability. Overexpression models complement knockout studies by showing sufficiency.
How EDITGENE Supports negative regulation of vascular permeability Research
Researchers studying negative regulation of vascular permeability-related genes often need to determine whether a candidate gene is causally involved in barrier protection or disruption. EDITGENE provides CRISPR-based cell models and screening services to enable these causal experiments.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of vascular permeability research.
Frequently Asked Questions About negative regulation of vascular permeability
What is GO:0043116 negative regulation of vascular permeability?
GO:0043116 is a biological process defined as any process that reduces the extent to which blood vessels can be pervaded by fluid.
What genes are involved in negative regulation of vascular permeability?
Genes such as NRP1, POLDIP2, HIF1A, and components of the Hedgehog pathway have been linked to this process.
How does Neuropilin-1 control vascular permeability?
Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions.
What is the role of the endothelial glycocalyx in vascular permeability?
The endothelial glycocalyx acts as a barrier that limits fluid extravasation and contributes to negative regulation of vascular permeability.
How is vascular permeability regulated in the skin?
Regulation of blood vascular permeability in the skin involves specialized mechanisms that maintain barrier function.
Does aging affect negative regulation of vascular permeability?
Physiological blood-brain transport is impaired with age by a shift in transcytosis, indicating that negative regulation of permeability changes over time.
What diseases are linked to impaired negative regulation of vascular permeability?
Sepsis-associated encephalopathy, hypertension, atherosclerosis, and age-related blood-brain barrier decline are linked to impaired barrier regulation.
How can CRISPR be used to study negative regulation of vascular permeability?
CRISPR knockout, knock-in, and overexpression models allow causal testing of genes that regulate endothelial barrier function.
What methods measure vascular permeability?
Transendothelial electrical resistance, albumin flux assays, and imaging of junctional proteins are common methods.
What is the role of hypoxia in vascular permeability?
Hypoxia-inducible factor-1 alpha regulates permeability of vascular endothelial cells, linking oxygen sensing to barrier control.
Conclusion
GO:0043116 negative regulation of vascular permeability is a critical biological process that preserves endothelial barrier function and protects against edema and inflammation. Key regulators such as Neuropilin-1 and the endothelial glycocalyx provide mechanistic entry points for research. Dysregulation of this process contributes to sepsis-associated encephalopathy, hypertension, atherosclerosis, and age-related blood-brain barrier decline. CRISPR-based models and permeability assays are essential tools for causal studies in this field.
References
- 1. Pal S et al.. 2024. Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions.. Angiogenesis 28(1):7 PMID: 39668325
- 2. Foote CA et al.. 2022. Endothelial Glycocalyx.. Compr Physiol 12(4):3781-3811 PMID: 35997082
- 3. Verhaar BJH et al.. 2020. Gut Microbiota in Hypertension and Atherosclerosis: A Review.. Nutrients 12(10) PMID: 33003455
- 4. Ono S et al.. 2017. Regulation of blood vascular permeability in the skin.. Inflamm Regen 37:11 PMID: 29259710
- 5. Yang AC et al.. 2020. Physiological blood-brain transport is impaired with age by a shift in transcytosis.. Nature 583(7816):425-430 PMID: 32612231
- 6. Niu C et al.. 2019. Metformin alleviates hyperglycemia-induced endothelial impairment by downregulating autophagy via the Hedgehog pathway.. Autophagy 15(5):843-870 PMID: 30653446
- 7. Kikuchi DS et al.. 2019. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.. J Neuroinflammation 16(1):241 PMID: 31779628
- 8. Hu DL et al.. 2019. [Regulation of hypoxia inducible factor-1α on permeability of vascular endothelial cells and the mechanism].. Zhonghua Shao Shang Za Zhi 35(3):209-217 PMID: 30897868
